Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | LegalView Re-launches Ketek Antibiotic Portal with Information on Drug's Potential Side EffectsLegalView has redeveloped and re-launched its Ketek practice area to alert patients of the antibiotic to its potentially fatal side effects.
By: Katie Kelley Ketek (telithromycin) Ketek was approved for market in 2004 and was part of a new class of drugs known as antimicrobial agents that "circumvent antibiotic resistance," While the FDA addressed the potential for liver damage among Ketek patients and relabeled the drug citing significant dangers associated with consuming the antibiotic, millions of individuals still take Ketek and remain exposed to the drug's potential side effects, which may have already caused unknown damage to a patient. Individuals who were given a prescription for Ketek are advised to contact a Ketek attorney who can provide a free legal consultation regarding development of any potential Ketek lawsuit where monetary compensation is a potential outcome and can be used to pay for the costly medical bills associated with treating liver failure and liver damage for an individual. Among the additional side effects, other than liver disease, associated with the drug include the following: slow heartbeat (bradycardia) About LegalView: LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at http://www.LegalView.com/ End
|
|